Log In
BCIQ
Print this Print this
 

ONCase PEG

  Manage Alerts
Collapse Summary General Information
Company AntiCancer Inc.
DescriptionRecombinant methioninase
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat metastatic cancer
Regulatory Designation
PartnerShionogi & Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today